Aarvik Therapeutics
Hayward, US · Founded 2020 · Delaware corporation · 1 known investors
Biotech
Founders & leadership
JR
Jagath Reddy JunutulaExecutive Officer, Director
AJ
Anula JayasuriyaDirector
SS
Sachdev SidhuDirector
RK
Ram Kalakoti ReddyDirector
RS
Richard SchellerDirector
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$1.2MraisedDec 2024 · 5 investors · PharmaceuticalsRule 506(b)
▶$1.2MraisedDec 2024 · 5 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Sachdev SidhuDirector
- Anula JayasuriyaDirector
- Jagath Reddy JunutulaExecutive Officer, Director
- Ram Kalakoti ReddyDirector
- Richard SchellerDirector
- Offering amount
- $15M
- Amount sold
- $1.2M
- First sale
- Nov 2024
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$8.3MraisedSep 2021 · 112 investors · PharmaceuticalsRule 506(b)
▶$8.3MraisedSep 2021 · 112 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Jagath Reddy JunutulaExecutive Officer, Director
- Anula JayasuriyaDirector
- Richard SchellerDirector
- Offering amount
- $8.3M
- Amount sold
- $8.3M
- Proceeds to insiders
- $500K
- First sale
- Aug 2021
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.